Pre-Open Stock Movers 10/10: (IPCI) (TSRO) (MYL) Higher; (TWTR) (BMY) (DOV) Lower (more...)
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- Twitter (TWTR) Tops Q3 EPS by 4c; Announces Restructuring, Workforce Reduction
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Pre-Open Stock Movers
Intellipharmaceutics International Inc. (Nasdaq: IPCI) 15.2% HIGHER; announced it received tentative approval from the U.S. Food and Drug Administration (FDA) for the Company's abbreviated new drug application (ANDA) for quetiapine fumarate extended-release tablets in the 50, 150, 200, 300 and 400 mg strengths. The Company's tentatively-approved product is a generic equivalent for the corresponding strengths of the branded product Seroquel XR® sold in the United States by Astra Zeneca Pharmaceuticals LP (AstraZeneca).
Tesaro (NASDAQ: TSRO) 14.3% HIGHER; positive NOVA Phase 3 trial details; upgraded at BofA/ML and price targets raised across the Street.
Twitter's (NYSE: TWTR) 13.9% LOWER; sale process is almost dead - Bloomberg
Mylan (NASDAQ: MYL) 12% HIGHER; agreed to the terms of a $465 million settlement with the DOJ and other government agencies that will resolve questions that have been raised about the classification of EpiPen for purposes of the Medicaid Drug Rebate Program. The company's 2016 guidance was also cut, but very little.
Bristol-Myers Squibb Co. (NYSE: BMY) 7.8% LOWER; Checkmate-026 data presented at ESMO was disappointing
Dover (NYSE: DOV) 6.8% LOWER; lowers 2016 guidance for revenue and EPS
Twilio (NYSE: TWLO) 4.2% LOWER; files to offer up to $400 million in common stock.
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) 3.3% LOWER; announced the presentation of preliminary data from the Companys Phase 1b/2 study of Ad-RTS-hIL-12 + veledimex following standard chemotherapy for the treatment of patients with locally advanced or metastatic breast cancer. The poster presentation, titled Phase 1b/2 study of intratumoral Ad-RTS-hIL-12+veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer, was presented at the European Society for Medical Oncology (ESMO) 2016 Congress today in Copenhagen, Denmark.
Merck (NYSE: MRK) 3% HIGHER; positive Keytruda data at ESMO.
Under Armour, Inc. (NYSE: UA) 2.2% HIGHER; Wells Fargo upgraded from Market Perform to Outperform
American Eagle Outfitters (NYSE: AEO) 2% HIGHER; BMO Capital upgraded from Market Perform to Outperform with a price target of $21.00
athenahealth (NASDAQ: ATHN) 2% HIGHER; Evercore ISI upgraded from Hold to Buy with a price target of $152.00.
Deere (NYSE: DE) 1.7% HIGHER; Wells Fargo upgraded from Market Perform to Outperform.
Netflix (NASDAQ: NFLX) 1.5% LOWER; Deutsche Bank initiated coverage with a Sell rating and a price target of $90
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 10/27: (PRQR) (OCN) (TWTR) Higher; (CYH) (GNC) (RNWK) Lower (more...)
- Pre-Open Stock Movers 10/24: (BEAV) (JPEP) (HLT) Higher; (BAS) (INO) (ADRO) Lower (more...)
- Tesla (TSLA) Sets New Start Time for Oct. 28th Solar Roof Event
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesDeutsche Bank, Bank of America, BMO Capital, Twitter, Tesla, Wells Fargo, Pre-Open Losers, Pre-Open Winners, Pre Market Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!